Company intelligence / Profile preview

Longeveron

Miami, Florida, United Stateslinkedin.com ↗

Ownership: Public · LGVN
Employees: ~45
Development stage: Phase 2

Overview

Longeveron's laromestrocel (Lomecel-B™) has shown positive safety and efficacy signals across multiple clinical trials. In HLHS, the company reported 100% five-year transplant-free survival in a Phase 1 trial versus a historical mortality rate of ~20%. For Alzheimer's disease, their Phase 2a CLEAR MIND study demonstrated improvements in cognitive function, quality of life, and brain volume. The FDA has agreed to consider BLA submission based on interim results from a single pivotal trial for AD. The company is advancing toward pivotal trials with regulatory clarity for both HLHS and AD programs.

Therapeutic areas: OtherCardiovascularNeurology
Modalities: Allogeneic mesenchymal stem cells (MSCs)Cellular therapy (medicinal signaling cells)
Industry: Biotech

Drug pipeline

6 assets

human mesenchymal stem cells (Longeveron)

5 more assets in the full pipeline.

Request access →

Partnerships

No major pharma partnerships disclosed as of May 2025. Seeking strategic partners to support late-stage development/commercialization efforts. Some private partner clinics participate in registry/treatment access outside the US.

Financials

Market cap: $20.2M
Total revenue: $287K
Enterprise value: $10.7M

Beyond the preview

Go deeper on Longeveron.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Longeveron.

Explore the full profile